Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Receivables (2017 - 2025)

Historic Receivables for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $182.2 million.

  • Organogenesis Holdings' Receivables rose 6416.28% to $182.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.2 million, marking a year-over-year increase of 6416.28%. This contributed to the annual value of $119.4 million for FY2024, which is 3441.18% up from last year.
  • Per Organogenesis Holdings' latest filing, its Receivables stood at $182.2 million for Q3 2025, which was up 6416.28% from $131.5 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Receivables ranged from a high of $182.2 million in Q3 2025 and a low of $72.0 million during Q1 2021
  • Its 5-year average for Receivables is $102.4 million, with a median of $98.7 million in 2022.
  • In the last 5 years, Organogenesis Holdings' Receivables skyrocketed by 12003.12% in 2021 and then tumbled by 725.69% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Receivables (Quarter) stood at $87.6 million in 2021, then grew by 9.36% to $95.8 million in 2022, then fell by 7.26% to $88.9 million in 2023, then soared by 34.41% to $119.4 million in 2024, then surged by 52.57% to $182.2 million in 2025.
  • Its last three reported values are $182.2 million in Q3 2025, $131.5 million for Q2 2025, and $112.4 million during Q1 2025.